Haya A. Aljami

Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trial

Mohammed J. F. Alenazi, H. Balkhy, S. Gilbert, 2021, The Lancet Microbe.

Humoral Immunogenicity and Efficacy of a Single Dose of ChAdOx1 MERS Vaccine Candidate in Dromedary Camels

A. Almansour, E. Azhar, S. Becker, 2019, Scientific Reports.

Heterogeneity of treatment effect of interferon-β1b and lopinavir–ritonavir in patients with Middle East respiratory syndrome by cytokine levels

Z. Memish, F. Hayden, R. Fowler, 2022, Scientific Reports.

Immunogenicity of High-Dose MVA-Based MERS Vaccine Candidate in Mice and Camels

Mohammed J. F. Alenazi, E. Azhar, A. Hashem, 2022, Vaccines.

Transcriptomic Profiling of Dromedary Camels Immunised with a MERS Vaccine Candidate

Paolo Ribeca, S. Gilbert, N. Alharbi, 2021, Veterinary sciences.

High Rate of Circulating MERS-CoV in Dromedary Camels at Slaughterhouses in Riyadh, 2019

A. Alsaleh, S. Alsagaby, N. Alharbi, 2020, Viruses.